Actively Recruiting
Digital Acceptance and Commitment Therapy App to Help Young Adults Quit Vaping in a Randomized Study
Led by Fred Hutchinson Cancer Center · Updated on 2026-07-23
1178
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This trial studies young adults aged 18 to 30 who use electronic cigarettes regularly and aims to evaluate a smartphone app called Acceptance and Commitment Therapy ACT on Vaping. This digital therapy is designed to help young adults quit vaping by promoting awareness of triggers and teaching skills tailored to their readiness to quit. The study focuses on supporting abstinence from all nicotine and tobacco products using accessible digital methods preferred by this age group. Participants are randomly assigned to one of two groups. One group uses the ACT on Vaping app with additional text messages to encourage quitting, along with incentivized text check-ins at 2 weeks, 2 months, and 4 months. The other group uses a version of the app with health education content and receives the same incentivized check-ins. After the intervention period, participants are followed up at 3, 5.5, and 6 months to assess vaping status and abstinence. During the study, participants complete regular surveys through the app and text messages to track their vaping habits and readiness to quit. The main outcome measured is abstinence from nicotine and tobacco confirmed by cotinine tests at 6 months. Additional outcomes include self-reported vaping abstinence, quit attempts, and changes in motivation to quit. The study involves using smartphones, responding to texts, and completing questionnaires over several months, with all procedures conducted in English and requiring access to mobile data or WiFi.
CONDITIONS
Brief Title
A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
Research Team
J
Jaimee Heffner, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here